Stryker Valuation

SYK Stock  EUR 348.50  4.30  1.25%   
At this time, the company appears to be fairly valued. Stryker has a current Real Value of €346.48 per share. The regular price of the company is €348.5. Our model measures the value of Stryker from inspecting the company fundamentals such as Operating Margin of 0.19 %, return on equity of 0.15, and Shares Outstanding of 378.83 M as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
348.50
Please note that Stryker's price fluctuation is very steady at this time. Calculation of the real value of Stryker is based on 3 months time horizon. Increasing Stryker's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Stryker stock is determined by what a typical buyer is willing to pay for full or partial control of Stryker. Since Stryker is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Stryker Stock. However, Stryker's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  348.5 Real  346.48 Hype  348.5 Naive  346.58
The real value of Stryker Stock, also known as its intrinsic value, is the underlying worth of Stryker Company, which is reflected in its stock price. It is based on Stryker's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Stryker's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
344.96
Downside
346.48
Real Value
383.35
Upside
Estimating the potential upside or downside of Stryker helps investors to forecast how Stryker stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Stryker more accurately as focusing exclusively on Stryker's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
343.61361.32379.03
Details
Hype
Prediction
LowEstimatedHigh
346.98348.50350.02
Details
Naive
Forecast
LowNext ValueHigh
345.06346.58348.09
Details

Stryker Total Value Analysis

Stryker is at this time estimated to have takeover price of 101.82 B with market capitalization of 92.13 B, debt of 11.86 B, and cash on hands of 1.84 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Stryker fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
101.82 B
92.13 B
11.86 B
1.84 B

Stryker Investor Information

About 80.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.82. Stryker recorded earning per share (EPS) of 5.83. The entity last dividend was issued on the 30th of March 2023. Based on the analysis of Stryker's profitability, liquidity, and operating efficiency, Stryker is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.

Stryker Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Stryker has an asset utilization ratio of 50.02 percent. This implies that the Company is making €0.5 for each dollar of assets. An increasing asset utilization means that Stryker is more efficient with each dollar of assets it utilizes for everyday operations.

Stryker Ownership Allocation

Stryker shows a total of 378.83 Million outstanding shares. The majority of Stryker outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Stryker to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Stryker. Please pay attention to any change in the institutional holdings of Stryker as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.

Stryker Profitability Analysis

The company reported the revenue of 18.45 B. Net Income was 2.36 B with profit before overhead, payroll, taxes, and interest of 11.65 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Stryker's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Stryker and how it compares across the competition.

About Stryker Valuation

The stock valuation mechanism determines Stryker's current worth on a weekly basis. Our valuation model uses a comparative analysis of Stryker. We calculate exposure to Stryker's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Stryker's related companies.
Stryker Corporation operates as a medical technology company. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan. STRYKER CORP operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 36000 people.

8 Steps to conduct Stryker's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Stryker's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Stryker's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Stryker's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Stryker's revenue streams: Identify Stryker's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Stryker's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Stryker's growth potential: Evaluate Stryker's management, business model, and growth potential.
  • Determine Stryker's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Stryker's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Stryker Stock analysis

When running Stryker's price analysis, check to measure Stryker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stryker is operating at the current time. Most of Stryker's value examination focuses on studying past and present price action to predict the probability of Stryker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stryker's price. Additionally, you may evaluate how the addition of Stryker to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated